AN2 Therapeutics, Inc.

NasdaqGS ANTX

AN2 Therapeutics, Inc. Share Price on January 14, 2025: USD 1.22

AN2 Therapeutics, Inc. Share Price is USD 1.22 on January 14, 2025, a -94.01% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

AN2 Therapeutics, Inc. 52-week high Share Price is USD 20.99 on February 05, 2024, which is 1,620.49% above the current Share Price.
AN2 Therapeutics, Inc. 52-week low Share Price is USD 0.98 on August 16, 2024, which is -19.67% below the current Share Price.
AN2 Therapeutics, Inc. average Share Price for the last 52 weeks is USD 3.32.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqGS: ANTX

AN2 Therapeutics, Inc.

CEO	Mr. Eric E. Easom
IPO Date	March 25, 2022
Location	United States
Headquarters	1800 El Camino Real
Employees	41
Sector	Health Care
Industries Pharmaceuticals Biotechnology Clinical Trials

Description

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

Key trends

Past 5 years